Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Fetal brain diffusion MRI in growth-restricted pregnancies

Official title: COMPARISON OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING FINDINGS IN FETUSES WITH AND WITHOUT FETAL GROWTH RESTRICTION: THE IMPACT OF MIDDLE CEREBRAL ARTERY DOPPLER FINDINGS

Run by Istanbul Training and Research Hospital · NCT07769957 · Data updated 2026-11-12

This study tests whether diffusion-weighted MRI can reveal differences in fetal brain tissue in growth-restricted pregnancies versus healthy pregnancies, using MCA Doppler patterns to help interpret the findings.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment120 (estimated)
SponsorIstanbul Training and Research Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedMarch 26, 2026
Main results expectedDecember 2029
Study endsDecember 2030
Registry record updatedAugust 20, 2026
Trial IDNCT07769957 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are pregnant individuals with singleton gestations between 28 and 38 weeks, including those with FGR (EFW or AC below the 10th percentile) and healthy controls (EFW/AC between the 10th and 90th percentiles) with normal Doppler and no major anomalies.

Probably not a fit

Pregnancies not meeting the imaging or Doppler criteria, or with contraindications to MRI, may not derive direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study compares regional brain diffusion measurements from diffusion-weighted MRI in fetuses with fetal growth restriction (FGR) to those in appropriately grown fetuses. Fetuses are grouped by FGR with normal MCA Doppler, FGR with MCA Doppler redistribution, and healthy controls with normal Doppler. MRI is performed at 1.5 Tesla, and fractional regions such as frontal, occipital, temporal white matter, thalamus, pons, cerebellum, and centrum semiovale are analyzed for apparent diffusion coefficient values. The primary aim is to identify differences in regional ADC values between FGR and controls; a secondary aim considers the relationship between MCA Doppler findings and ADC patterns. This is an observational, non-interventional study designed to explore potential brain diffusion changes associated with FGR.

Why it matters

Potential benefit: If successful, the findings could improve understanding of fetal brain changes in FGR and guide future diagnostics or monitoring strategies.

How similar studies have gone: Past work in fetal MRI has demonstrated the feasibility of diffusion measurements, though this study focuses on correlating diffusion with Doppler patterns in FGR.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton pregnancy
* Gestational age between 28 and 38 weeks
* Maternal age between 18 and 45 years
* For the FGR groups: estimated fetal weight (EFW) below the 10th percentile and/or abdominal circumference (AC) below the 10th percentile
* For the control group: EFW and AC between the 10th and 90th percentiles, normal fetal Doppler findings, and no major structural anomaly on fetal anatomical examination
* Written informed consent for participation in the study

Exclusion Criteria:

* Multiple pregnancy
* Major fetal structural anomaly or diagnosed chromosomal abnormality
* Contraindication to MRI, such as an MRI-incompatible implant
* Maternal uncontrolled diabetes mellitus, significant thyroid disease, severe uncontrolled chronic hypertension, or other significant systemic chronic disease
* Maternal age below 18 or above 45 years
* Inability or unwillingness to provide informed consent or cooperate with study procedures

Where it's running

  • Istanbul Training and Research Hospital Department of Obstetrics and Gynecology
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation

    This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.

    Recruiting at 2 sites Makerere University · Kampala and 1 other locations · NCT07844876

  • ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging

    This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.

    Recruiting at 4 sites Medicines360 · Bridgeport, Connecticut and 4 other locations · NCT07669935

  • AI-based ultrasound and MRI to predict outcomes in placental-related fetal growth restriction

    This project will test whether combining AI analysis of ultrasound and MRI with standard fetal monitoring can predict short- and long-term outcomes for pregnancies affected by early-onset, placental-related fetal growth restriction.

    Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT07473739

  • How the placenta affects maternal and fetal health

    This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.

    Recruiting University of Oxford · Oxford · NCT07470320

  • Amniotic fluid and the extremely preterm baby's gut

    We will see if amniotic fluid from extremely preterm births (24+0 to 27+6 weeks) shows changes that relate to gut problems such as necrotizing enterocolitis or sepsis in very preterm infants.

    Recruiting at 2 sites Maxima Medical Center · Amsterdam and 1 other locations · NCT07152106

  • Examining how assisted reproductive technologies affect pregnancy outcomes

    This study is trying to see if different assisted reproductive technologies affect the health of pregnancies and if they are linked to risks like growth problems or stillbirth.

    Recruiting Aristotle University Of Thessaloniki · Pleven and 5 other locations · NCT06918236

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.